在2017年世界肾脏日之际；肥胖及其与慢性肾脏病的关系。
On the occasion of world kidney day 2017; obesity and its relationship with chronic kidney disease.
作者信息
Mahmoodnia Leila, Tamadon Mohammad Reza
机构信息
Department of Internal Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Department of Internal Medicine, Semnan University of Medical Science, Semnan, Iran.
出版信息
J Nephropathol. 2017 Jul;6(3):105-109. doi: 10.15171/jnp.2017.18. Epub 2017 Jan 5.
Abstract
CONTEXT
Numerous studies have reported the impact of obesity in the incidence of chronic kidney disease (CKD). Some studies have suggested the direct role of obesity in the incidence of CKD, while some other studies suggest an indirect effect caused by the effects of obesity on blood pressure and diabetes.
EVIDENCE ACQUISITION
PubMed, EBSCO, Web of Science, directory of open access journals (DOAJ), EMBASE, and Google Scholar have been searched.
RESULTS
Recent studies have presented more strong evidences on the role of obesity on the incidence of CKD. The double role of obesity in the incidence of CKD has also been mentioned in some studies.
CONCLUSIONS
Such an additional effect arises from the impact of obesity on the incidence of some conditions and diseases such as cardiovascular disease, hypertension, and diabetes, which in turn are involved in the incidence of CKD and are considered as its risk factors.
摘要
背景
众多研究报告了肥胖对慢性肾脏病（CKD）发病率的影响。一些研究表明肥胖在CKD发病中起直接作用，而其他一些研究则表明肥胖通过对血压和糖尿病的影响产生间接作用。
证据获取
检索了PubMed、EBSCO、科学引文索引（Web of Science）、开放获取期刊目录（DOAJ）、荷兰医学文摘数据库（EMBASE）和谷歌学术。
结果
近期研究提供了更多关于肥胖在CKD发病中作用的有力证据。一些研究也提到了肥胖在CKD发病中的双重作用。
结论
这种额外作用源于肥胖对某些疾病如心血管疾病、高血压和糖尿病发病率的影响，而这些疾病又与CKD的发病有关并被视为其危险因素。
相似文献
1
On the occasion of world kidney day 2017; obesity and its relationship with chronic kidney disease.在2017年世界肾脏日之际；肥胖及其与慢性肾脏病的关系。
J Nephropathol. 2017 Jul;6(3):105-109. doi: 10.15171/jnp.2017.18. Epub 2017 Jan 5.
2
The link between chronic kidney disease and cardiovascular disease.慢性肾病与心血管疾病之间的联系。
J Nephropathol. 2014 Jul;3(3):99-104. doi: 10.12860/jnp.2014.19. Epub 2014 Jul 1.
3
On the occasion of world kidney day 2016; work together to better protect the kidney.在2016年世界肾脏日之际；共同努力更好地保护肾脏。
J Nephropathol. 2016 Jan;5(1):15-8. doi: 10.15171/jnp.2016.03. Epub 2015 Apr 20.
4
Obesity and kidney protection.肥胖与肾脏保护
J Nephropathol. 2014 Jul;3(3):91-7. doi: 10.12860/jnp.2014.18. Epub 2014 Jul 1.
5
Dermatological diseases in patients with chronic kidney disease.慢性肾脏病患者的皮肤病
J Nephropathol. 2013 Apr;2(2):104-9. doi: 10.12860/JNP.2013.17. Epub 2013 Apr 1.
6
A story of microalbuminuria and diabetic nephropathy.一个关于微量白蛋白尿和糖尿病肾病的故事。
J Nephropathol. 2013 Oct;2(4):234-40. doi: 10.12860/JNP.2013.37. Epub 2013 Oct 1.
7
Dietary antioxidents and oxidative stress in predialysis chronic kidney disease patients.透析前慢性肾病患者的膳食抗氧化剂与氧化应激
J Nephropathol. 2012 Oct;1(3):134-42. doi: 10.5812/nephropathol.8108. Epub 2012 Oct 1.
8
Turmeric: Reemerging of a neglected Asian traditional remedy.姜黄：一种被忽视的亚洲传统药物的再度兴起。
J Nephropathol. 2012 Apr;1(1):17-22. doi: 10.5812/jnp.5. Epub 2012 Apr 5.
9
Place of mTOR inhibitors in management of BKV infection after kidney transplantation.mTOR抑制剂在肾移植后BK病毒感染管理中的地位。
J Nephropathol. 2016 Jan;5(1):1-7. doi: 10.15171/jnp.2016.01. Epub 2015 Dec 20.
10
The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.肥胖及其生物临床相关因素在慢性肾脏病进展中的作用。
Adv Chronic Kidney Dis. 2006 Oct;13(4):352-64. doi: 10.1053/j.ackd.2006.07.010.
引用本文的文献
1
Factors affecting knowledge and practices towards prevention of chronic kidney disease among hypertensive patients at public hospital in Bale and East Bale zone, Oromia, Southeast Ethiopia, 2023: A cross-sectional study.2023年埃塞俄比亚东南部奥罗米亚州巴勒和东巴勒地区公立医院高血压患者预防慢性肾脏病的知识和行为影响因素：一项横断面研究
Medicine (Baltimore). 2025 Mar 28;104(13):e41989. doi: 10.1097/MD.0000000000041989.
2
Novel Asian-Specific Visceral Adiposity Indices Are Associated with Chronic Kidney Disease in Korean Adults.新型亚洲特有的内脏脂肪指数与韩国成年人的慢性肾脏病相关。
Diabetes Metab J. 2023 May;47(3):426-436. doi: 10.4093/dmj.2022.0099. Epub 2023 Mar 6.
3
Chronic kidney disease and its health-related factors: a case-control study.慢性肾脏病及其相关健康因素：病例对照研究。
BMC Nephrol. 2022 Jan 10;23(1):24. doi: 10.1186/s12882-021-02655-w.
4
Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1.肥胖与慢性肾脏病进展——一种新型脂肪细胞因子：C1q/肿瘤坏死因子相关蛋白-1的作用
Clin Kidney J. 2018 Oct 11;12(3):420-426. doi: 10.1093/ckj/sfy095. eCollection 2019 Jun.
5
Association between Take-Out Food Consumption and Obesity among Chinese University Students: A Cross-Sectional Study.外卖食品消费与中国大学生肥胖的关系：一项横断面研究。
Int J Environ Res Public Health. 2019 Mar 25;16(6):1071. doi: 10.3390/ijerph16061071.
6
Gastric sleeve surgery in hemodialysis: A case report.血液透析患者的胃袖状切除术：一例报告。
Int J Surg Case Rep. 2019;57:19-21. doi: 10.1016/j.ijscr.2019.02.041. Epub 2019 Mar 5.
7
Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease?低碳水化合物饮食在糖尿病和非糖尿病慢性肾脏病患者中安全吗？
Ann N Y Acad Sci. 2020 Feb;1461(1):25-36. doi: 10.1111/nyas.13997. Epub 2019 Jan 15.
8
Association between MCP-1 2518 A>G gene polymorphism and chronic kidney disease.MCP-1 2518 A>G基因多态性与慢性肾脏病之间的关联
Int Urol Nephrol. 2018 Dec;50(12):2245-2253. doi: 10.1007/s11255-018-1955-1. Epub 2018 Aug 14.
9
Impact of Dapagliflozin Therapy on Renal Protection and Kidney Morphology in Patients With Uncontrolled Type 2 Diabetes Mellitus.达格列净治疗对血糖控制不佳的2型糖尿病患者肾脏保护及肾脏形态的影响
J Clin Med Res. 2018 Jun;10(6):466-477. doi: 10.14740/jocmr3419w. Epub 2018 Apr 13.
本文引用的文献
1
Abdominal Obesity, Race and Chronic Kidney Disease in Young Adults: Results from NHANES 1999-2010.年轻成年人的腹部肥胖、种族与慢性肾脏病：1999 - 2010年美国国家健康与营养检查调查结果
PLoS One. 2016 May 25;11(5):e0153588. doi: 10.1371/journal.pone.0153588. eCollection 2016.
2
The dual roles of obesity in chronic kidney disease: a review of the current literature.肥胖在慢性肾脏病中的双重作用：当前文献综述
Curr Opin Nephrol Hypertens. 2016 May;25(3):208-16. doi: 10.1097/MNH.0000000000000212.
3
Metabolically Healthy Obesity and Development of Chronic Kidney Disease: A Cohort Study.代谢健康型肥胖与慢性肾脏病的发生发展：一项队列研究。
Ann Intern Med. 2016 Mar 1;164(5):305-12. doi: 10.7326/M15-1323. Epub 2016 Feb 9.
4
Effect of sour tea (Lipicom) pill versus captopril on the treatment of hypertension.酸茶（力比可）丸与卡托普利治疗高血压的疗效比较
J Renal Inj Prev. 2015 Sep 1;4(3):73-9. doi: 10.12861/jrip.2015.15. eCollection 2015.
5
Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease.权衡证据：肥胖、代谢综合征与慢性肾脏病风险
BMC Nephrol. 2015 Aug 7;16:133. doi: 10.1186/s12882-015-0137-y.
6
Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort.中国城市队列中伴有和不伴有代谢综合征的超重与肥胖人群的慢性肾脏病
BMC Nephrol. 2015 Jun 18;16:85. doi: 10.1186/s12882-015-0083-8.
7
Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.肥胖诱导的高血压：神经体液机制与肾脏机制的相互作用
Circ Res. 2015 Mar 13;116(6):991-1006. doi: 10.1161/CIRCRESAHA.116.305697.
8
Elevated body mass index as a risk factor for chronic kidney disease: current perspectives.体重指数升高是慢性肾脏病的危险因素：当前观点。
Diabetes Metab Syndr Obes. 2014 Jul 29;7:347-55. doi: 10.2147/DMSO.S46674. eCollection 2014.
9
Risk factors for chronic kidney disease: an update.慢性肾脏病的危险因素：最新进展
Kidney Int Suppl (2011). 2013 Dec;3(4):368-371. doi: 10.1038/kisup.2013.79.
10
The association between individual and combined components of metabolic syndrome and chronic kidney disease among African Americans: the Jackson Heart Study.非裔美国人中代谢综合征的个体及综合组分与慢性肾脏病之间的关联：杰克逊心脏研究
PLoS One. 2014 Jul 3;9(7):e101610. doi: 10.1371/journal.pone.0101610. eCollection 2014.
Zotero 插件